My Portfolio
+
LINK YOUR PORTFOLIO

Fulgent Genetics Inc FLGT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
18.14UNCH (UNCH)
Volume
10,638
Close
18.14quote price arrow down-0.56 (-2.99%)
Volume
697,877
52 week range
13.46 - 31.04
Loading...
  • Open18.60
  • Day High19.14
  • Day Low18.08
  • Prev Close18.70
  • 52 Week High31.04
  • 52 Week High Date11/25/25
  • 52 Week Low13.46
  • 52 Week Low Date03/03/26

Latest On Fulgent Genetics Inc

Key Stats

  • Market Cap515.187M
  • Shares Out28.40M
  • 10 Day Average Volume0.58M
  • Dividend-
  • Dividend Yield-
  • Beta0.92

Latest On Fulgent Genetics Inc

KEY STATS

  • Open18.60
  • Day High19.14
  • Day Low18.08
  • Prev Close18.70
  • 52 Week High31.04
  • 52 Week High Date11/25/25
  • 52 Week Low13.46
  • 52 Week Low Date03/03/26
  • Market Cap515.187M
  • Shares Out28.40M
  • 10 Day Average Volume0.58M
  • Dividend-
  • Dividend Yield-
  • Beta0.92

RATIOS/PROFITABILITY

  • EPS (TTM)-2.40
  • P/E (TTM)-7.57
  • Fwd P/E (NTM)-11.93
  • EBITDA (TTM)-81.805M
  • ROE (TTM)-6.78%
  • Revenue (TTM)320.346M
  • Gross Margin (TTM)38.71%
  • Net Margin (TTM)-23.41%
  • Debt To Equity (MRQ)0.21%

EVENTS

  • Earnings Date07/30/2026(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
Fulgent Genetics, Inc. is a technology-based company with a laboratory services business and a therapeutic development business. Its laboratory services business includes technical laboratory and testing services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a range of cancers using a novel nanoencapsulation and targeted therapy platform designed to...
Ming Hsieh
Chairman of the Board, Chief Executive Officer
Jian Xie
President, Chief Operating Officer
Paul Kim CPA
Chief Financial Officer
Address
4399 SANTA ANITA AVE
El Monte, CA
91731
United States